SEC Filings
Ultomiris Gets US Accelerated Approval In IgA Nephropathy On A 43.4% Proteinuria Reduction
The approval rests on a lab marker, not proof of slower kidney decline, and kidney-function data from the I CAN trial are still pending.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
SEC Filings
The approval rests on a lab marker, not proof of slower kidney decline, and kidney-function data from the I CAN trial are still pending.
Earnings
North American irrigation and road safety sales recovered in the August quarter, yet the full year still closed with lower sales and profit.
Earnings
Reported income rose 26.1% in the third quarter, but consulting profit fell and a Commerce Department stake in Anderon is now on the balance sheet.
Earnings
Third-quarter net income fell to $156 million on a year-earlier tax benefit, while loans, deposits and credit sales grew.
Earnings
Third-quarter revenue rose 10.0% to $3.10 billion, and adjusted earnings guidance moved up to $11.25 to $11.35 a share.
Earnings
CEO Randall Stuewe says timing of renewable diesel sales held back the venture's third quarter and should help the fourth.
SEC Filings
The board added a penny to the regular payout; holders of record on December 8 get paid December 18.
Earnings
Dover's 10-Q shows heavy buybacks, two small deals and a current euro note carried at $683.4 million.
SEC Filings
An 8-K says Quest learned of the access Wednesday, called in federal law enforcement and says operations were not materially disrupted.
Earnings
Fee profit rose 6% in the third quarter, but realized performance revenues dropped 38% and assets under management grew 10%.
Earnings
Used truck pricing and a freight recovery lifted Fleet Management earnings 21% to $177 million, and Ryder is adding $300 million of rental fleet spending.
SEC Filings
The card lender's September update shows fewer past-due dollars than a year earlier, alongside a larger loan book.